Fig. 2
- ID
- ZDB-IMAGE-241015-32
- Publication
- Melikishvili et al., 2024 - Effectiveness of add-on acetazolamide in children with drug-resistant CHD2-related epilepsy and in a zebrafish CHD2 model
- All Figures
- Figures for Melikishvili et al., 2024
Fig. 2 Antisense knockdown of chd2 in zebrafish larvae—morphological and electrophysiological analysis (A) chd2 knockdown and non-injected control zebrafish larvae at 5 dpf. (B-C) Local field potential (LFP) recording revealed epileptiform events in 5-dpf chd2 knockdown larvae; chd2 knockdown larvae exhibited an increase in ictal-like events compared to non-injected control larvae at 5 dpf, non-injected control larvae with a mean of 0.29 ± 0.18 (SEM), chd2 knockdown larvae with a mean of 3.29 ± 0.77, chd2 knockdown treated with 1 mM acetazolamide with a mean of 0.92 ± 0.29, chd2 knockdown treated with 100 μM fenfluramine overnight with a mean of 2.0 ± 0.64 ictal-like events. Statistical analysis by one-way ANOVA showed that treatment with 1 mM acetazolamide significantly reduced ictal-like events (p < 0.05), but that for 100 μM fenfluramine, the result was not significant (p > 0.29), with all groups passing the D'Agostino-Pearson normality test.